Erajaya Swasembada Tbk. vs Indofarma Tbk. — how do they compare? Erajaya Swasembada Tbk. trades at Rp595 (market cap 9.41T, 91.64M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Erajaya Swasembada Tbk. is far larger — about 24.1× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| ERAA | INAF | |
|---|---|---|
Market Cap | 9.41T | 390.51B |
Volume | 91.64M | — |
Lot | 916.38K | — |
Turnover | 53.7B | — |
Average Price | 585.95 | — |
Value | 53.7B | — |
Indicative Equilibrium Price | 595 | — |
Indicative Equilibrium Volume | 32.64K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Erajaya Swasembada Tbk (the Company) was established in Jakarta based on Notarial Deed No.7 of Myra Yuwono, S.H., dated October 8, 1996. Erajaya Group is the official distributor for 10 international mobile communication brands and an authorised partner for major mobile operators. Recently, the Group has launched its own mobile handset under the name of Venera. In 1996, PT Erajaya Swasembada, or Erajaya, the establishment of what we know today as the Erajaya Group, was incorporated.
Read more on ERAA →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →